John A. Ward

Array ( [id] => 1349669 [patent_doc_number] => 06583276 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Angiogenic factors and use thereof in treating cardiovascular disease' [patent_app_type] => B1 [patent_app_number] => 09/037983 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 29728 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583276.pdf [firstpage_image] =>[orig_patent_app_number] => 09037983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4131850 [patent_doc_number] => 06034072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'IL-2 gene expression and delivery systems and uses' [patent_app_type] => 1 [patent_app_number] => 9/012366 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 11 [patent_no_of_words] => 17133 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034072.pdf [firstpage_image] =>[orig_patent_app_number] => 012366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082369 [patent_doc_number] => 20020082224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'NON-IMMUNOGENIC PRODRUGS AND SELECTABLE MARKERS FOR USE IN GENE THERAPY' [patent_app_type] => new [patent_app_number] => 09/006298 [patent_app_country] => US [patent_app_date] => 1998-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082224.pdf [firstpage_image] =>[orig_patent_app_number] => 09006298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103192 [patent_doc_number] => 06100242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Gene therapies for enhancing cardiac function' [patent_app_type] => 1 [patent_app_number] => 8/722271 [patent_app_country] => US [patent_app_date] => 1997-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 10844 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100242.pdf [firstpage_image] =>[orig_patent_app_number] => 722271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234633 [patent_doc_number] => 06143551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria' [patent_app_type] => 1 [patent_app_number] => 8/999391 [patent_app_country] => US [patent_app_date] => 1997-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 8552 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143551.pdf [firstpage_image] =>[orig_patent_app_number] => 999391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420473 [patent_doc_number] => 06177410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Therapeutic methods for prostate cancer' [patent_app_type] => 1 [patent_app_number] => 8/986106 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 9 [patent_no_of_words] => 17125 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177410.pdf [firstpage_image] =>[orig_patent_app_number] => 986106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093417 [patent_doc_number] => 06096534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells' [patent_app_type] => 1 [patent_app_number] => 8/875509 [patent_app_country] => US [patent_app_date] => 1997-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 14538 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096534.pdf [firstpage_image] =>[orig_patent_app_number] => 875509 [rel_patent_id] =>[rel_patent_doc_number] =>)